The Guru Edge consists of comprehensive, industry-guiding services, tools, and educational resources that accelerate your success
In contrast to DRD2 in prolactinomas, the expression of FLNA in GH-secreting tumors did not correlate with SSTR2 levels, and FLNA silencing in human tumoral cells did not affect SSTR2 expression and membrane localization
Both peptides were removed from permissible compounding in February 2024 under FDA guidance
Whether you are lifting, working out or running a marathon, L-Arginine can help you go the extra mile
For researchers interested in the broader GLP-1 research landscape, see our overviews of Semaglutide, Tirzepatide vs Semaglutide, and Retatrutide the first triple GLP-1/GIP/glucagon agonist